1. Home
  2. Analysis
  3. Digoxin
  4. Ninlaro

Digoxin and Ninlaro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Ninlaro (ixazomib citrate). Common drug interactions include dizziness among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Ninlaro. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Ninlaro?

Ninlaro has active ingredients of ixazomib citrate. eHealthMe is studying from 19,563 Ninlaro users. Check the latest studies of Ninlaro.

On Jul, 13, 2026

75 people who take Digoxin and Ninlaro together, and have interactions are studied.

Digoxin and Ninlaro drug interactions.

What are the common drug interactions of Digoxin and Ninlaro, by gender? *:

female:

  1. Dizziness
  2. Dry skin
  3. Feeling hot
  4. Headache (pain in head)
  5. Hip fracture
  6. Hypersensitivity
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Ill-defined disorder
  9. Immunodeficiency
  10. Intracardiac thrombus (presence of a circumscribed mass with heart wall)

male:

  1. Asthenia (weakness)
  2. Platelet count decreased
  3. Joint swelling
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Peripheral swelling
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Vision blurred
  9. Anaemia (lack of blood)
  10. Furuncle (infection of the hair follicle)

What are the common drug interactions of Digoxin and Ninlaro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Herpes zoster

50-59:

  1. Anaemia (lack of blood)
  2. Fatigue (feeling of tiredness)
  3. Haemoglobin decreased
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

  1. Joint swelling
  2. Peripheral swelling
  3. Vision blurred
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Platelet count decreased
  6. Abdominal pain lower
  7. Aphasia (damage to the parts of the brain that control language)
  8. Asthenia (weakness)
  9. Bladder cancer
  10. Blindness

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 75 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Ninlaro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Ninlaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ninlaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ninlaro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on digoxin and ixazomib citrate (the active ingredients of Digoxin and Ninlaro, respectively), and Digoxin and Ninlaro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.